Abiopharma

🔍 Ali Asif (Executive)

Company: Protagonist Therapeutics, Inc (PTGX)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 25,600 shares of Common Stock (Direct)
  Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 86,665.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 32,000 shares of Stock Option (right to buy) at $87.18 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 32,000.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents grant of restricted stock units payable solely in common stock that will vest in four equal annual installments on January 15, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
• F2: The stock option vests in 48 equal monthly installments following January 2, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.